Fragile X syndrome (FXS), caused by loss of FMR1 gene function, is the most common heritable cause of intellectual disability and autism spectrum disorders. The FMR1 protein (FMRP) translational regulator mediates activitydependent control of synapses. In addition to the metabotropic glutamate receptor (mGluR) hyperexcitation FXS theory, the GABA theory postulates that hypoinhibition is causative for disease state symptoms. Here, we use the Drosophila FXS model to assay central brain GABAergic circuitry, especially within the Mushroom Body (MB) learning center. All 3 GABA A receptor (GABA A R) subunits are reportedly downregulated in dfmr1 null brains. We demonstrate parallel downregulation of glutamic acid decarboxylase (GAD), the rate-limiting GABA synthesis enzyme, although GABAergic cell numbers appear unaffected. Mosaic analysis with a repressible cell marker (MARCM) single-cell clonal studies show that dfmr1 null GABAergic neurons innervating the MB calyx display altered architectural development, with early underdevelopment followed by later overelaboration. In addition, a new class of extra-calyx terminating GABAergic neurons is shown to include MB intrinsic α/β Kenyon Cells (KCs), revealing a novel level of MB inhibitory regulation. Functionally, dfmr1 null GABAergic neurons exhibit elevated calcium signaling and altered kinetics in response to acute depolarization. To test the role of these GABAergic changes, we attempted to pharmacologically restore GABAergic signaling and assay effects on the compromised MB-dependent olfactory learning in dfmr1 mutants, but found no improvement. Our results show that GABAergic circuit structure and function are impaired in the FXS disease state, but that correction of hypoinhibition alone is not sufficient to rescue a behavioral learning impairment.
Introduction
GABAergic dysfunction is implicated in a range of neurodevelopmental disorders, including autism, epilepsy, Rett syndrome, and Fragile X syndrome (FXS) (Coghlan et al., 2012; D'Hulst and Kooy, 2007, 2009; Gatto and Broadie, 2010; Paluszkiewicz et al., 2010; Pizzarelli et al., 2011) . In mouse and Drosophila FXS disease models, GABAergic deficiencies include depressed glutamic acid decarboxylase (gad) mRNA (D'Hulst et al., 2009 ) and GABA A receptor (GABA A R) mRNA/protein levels (Adusei et al., 2010; Curia et al., 2009; D'Hulst et al., 2006; Gantois et al., 2006; Idrissi et al., 2005) . GABAergic functional defects also occur in Fragile X mental retardation 1 (FMR1) knockout mice. In the hippocampus, there is decreased GABAergic tonic inhibition (Curia et al., 2009 ). In the amygdala, both tonic and phasic inhibitory currents are reduced (Olmos-Serrano et al., 2010) . Striatal spiny neurons display increased spontaneous inhibitory current frequency, with reduced paired-pulse ratio of evoked inhibitory currents (Centonze et al., 2008) , consistent with reported fronto-striatal circuit disruption in clinical FXS (Menon et al., 2004) . Together, these findings indicate depressed GABAergic function in the FXS disease state (Paluszkiewicz et al., 2010) , suggesting GABAergic therapeutic treatment potential. The first such trial was conducted in the Drosophila FXS model, with a chemical screen demonstrating that feeding GABA or GABA reuptake inhibitors prevents a host of Drosophila FMR1 (dfmr1) null phenotypes (Chang et al., 2008) .
With only 3000 GABAergic neurons in the genetically-tractable Drosophila brain (Buchner et al., 1988; Chiang et al., 2011 ), this disease model provides an accessible system for testing GABAergic circuit Abbreviations: 2iL, 2nd instar larval; AEL, after egg lay; ANOVA, analysis of variance; APL, anterior paired lateral; BSA, bovine serum albumin; ChAT, choline acetyltransferase; CS+, conditioned stimulus; CS−, control stimulus; dBrainbow, Drosophila Brainbow; dfmr1, Drosophila FMR1; dFMRP, Drosophila Fragile X mental retardation protein; DSHB, Developmental Studies Hybridoma Bank; FasII, Fasciclin II; FLP, flippase; FMR1, Fragile X mental retardation 1; FMRP, Fragile X mental retardation protein; FRT, FLP recombination target; FXS, Fragile X syndrome; GABA A R, GABA A receptor; GAD, glutamic acid decarboxylase; HITS-CLIP, high-throughput sequencing of RNA isolated by crosslinking immunoprecipitation; HS, heat-shock; KC, Kenyon Cell; LI, learning index; MARCM, mosaic analysis with a repressible cell marker; MB, Mushroom Body; MCH, 4-methylcyclohexanol; mGluR, metabotropic glutamate receptor; NGS, normal goat serum; NipA, nipecotic acid; OCT, 3-octanol; P1, pupal day 1; PBS, phosphate buffered saline; PBST, 0.2% triton X-100 in PBS; PN, projection neuron; RDL, resistance to dieldrin. ☆ Conflict of interest: The authors declare the absence of any commercial or financial relationships that could be possibly construed as a potential conflict of interest.
